Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Pancreas Cancer
- Pancreatic Cancer
- Pancreatic Diseases
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03269994
- Collaborators
- Indiana University
- Massachusetts General Hospital
- Thomas Jefferson University
- Intermountain Health Care, Inc.
- Milton S. Hershey Medical Center
- Albany Medical College
- Rhode Island Hospital
- Hackensack Meridian Health
- Sunnybrook Health Sciences Centre, Canada
- University of Iowa
- Montefiore Medical Center/Albert Einstein College of Medicine
- Stony Brook Medicine
- Washington University School of Medicine
- Advocate Illinois Masonic Medical Center
- Hamilton Health Sciences Center
- University of Texas Southwestern Medical Center
- North Shore University HealthSystem
- Baptist Memorial Health Care Corporation
- Providence Health & Services
- Baylor Scott and White Health
- University of Utah
- Northwestern University
- Jersey Shore Medical Center (Hackensack Meridian)
- The Cleveland Clinic
- Temple University
- Emory University
- The Ohio State University Wexner Medical Center
- University of California, Davis
- Mount Sinai Hospital, New York
- University of Chicago
- Universtiy of Mississippi Medical Center
- Brody School of Medicine at East Carolina University
- Fox Chase Cancer Center
- Gundersen Lutheran Medical Center
- The Ottowa Hospital/University of Ottowa
- University of Wisconsin, Madison
- Johns Hopkins University
- Investigators
- Principal Investigator: Michael D'Angelica, MD Memorial Sloan Kettering Cancer Center
Get Well Soon